Press release
Neurodegenerative Disease Market to Reach $60.52 Billion by 2030, Growing at 4.3% CAGR
Neurodegenerative Disease Market
According to the latest research by InsightAce Analytic, the global Neurodegenerative Disease market will be valued at US$ 41.79 Billion in 2021. It is expected to reach US$ 60.52 Billion by 2030, with a CAGR of 4.3% during a forecast period of 2022-2030.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1097
The neurodegenerative disease continues to significantly negatively impact the population's mental and physical health and worldwide healthcare costs. All conditions that harm a person's brain's neurons are categorized as neurodegenerative disorders. With 5.8 million predicted instances of Alzheimer's dementia in the U.S. alone in 2019, Alzheimer's disease is the most common neurological condition. Huntington's disease, spinal muscular atrophy, multiple system atrophy, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, and others are neurodegenerative disorders.
The market for neurological diseases that are caused by neurodegenerative diseases includes the sale of medicines for those diseases as well as services that are associated with them. One of the main factors propelling the growth of the neurodegenerative disease market is the rise in the frequency of neurodegenerative disorders brought on by the aging population. A class of terminal illnesses known as neurodegenerative disorders primarily affects the human brain's neurons, causing gradual degenerative alterations or the death of nerve cells. The rising prevalence of neurodegenerative diseases among the world's population fuels the expansion of the market for therapies for these diseases. The majority of neurological illnesses are increasing as the senior population expands. The market for treating neurological disorders has faced a substantial challenge due to the high failure rates of clinical trials and research and development (R&D). Although many companies are investing regularly in R&D to develop therapy alternatives for neurodegenerative illnesses, few of these therapies are now authorized.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02
North America is anticipated to contribute to the Neurodegenerative Disease market. The North American market's growth is driven by factors such as rising medicine demand, high costs, rising R&D expenditure, and favorable health reimbursement policies. In addition, the Asia Pacific Neurodegenerative Disease market is expected to register significant growth because of the aging population, high frequency of neurological illnesses, and increased demand for medications for Parkinson's and Alzheimer's disease in China and Japan.
Major market players operating in the Neurodegenerative Disease market include
Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi, GlaxoSmithKline and Other Key Players
Recent collaborations and agreements in the market:
• In March 2019, Novartis said that Mayzent had been approved by the FDA (siponimod). It is regarded as the first approved therapy for those with secondary progressive multiple sclerosis (SPMS). It is intended for patients who are 15 years of age and older.
• In January 2018, AVONEX, TYSABRI, and TECFIDERA began to be jointly promoted by Biogen Japan Ltd. and Eisai Co., Ltd. Biogen Japan produces them as a multiple sclerosis treatment. They will provide details on how these medications are used in hospitals.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1097
Market Segments
Global Neurodegenerative Disease Market, by Drug Class, 2022-2030 (Value US$ Mn)
• NMDA
• SSRIs
• Dopamine Inhibitors
Global Neurodegenerative Disease Market, by Application, 2022-2030 (Value US$ Mn)
• Parkinson's Disease
• Huntington Disease
• Amyotrophic Lateral Sclerosis
• Alzheimer's Disease
Global Neurodegenerative Disease Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Neurodegenerative Disease Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Neurodegenerative Disease Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Neurodegenerative Disease Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Neurodegenerative Disease Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Neurodegenerative Disease Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Neurodegenerative Disease market
To receive an industry overview and future trends of the Neurodegenerative Disease market
To analyze the Neurodegenerative Disease market drivers and challenges
To get information on the Neurodegenerative Disease market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Neurodegenerative Disease market industry
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurodegenerative Disease Market to Reach $60.52 Billion by 2030, Growing at 4.3% CAGR here
News-ID: 3891651 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Rare Earth Metals Recycling Market expected to Witness Huge Revenue Growth to 20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rare Earth Metals Recycling Market Size, Share & Trends Analysis Report By Application (Alloy, Catalyst, Permanent Magnets, Glass, Ceramics, Phosphor, Polishing Materials And Hydrogen Storage Alloy), Source (FCC, Fluorescent Lamps, Magnets, Batteries And Industrial Processes) And Technology (Hydrometallurgical And Pyrometallurgical)- Market Outlook And Industry Analysis 2034"
The global rare earth metals recycling market is estimated to…
Rapid Prototyping Materials Market Current Scenario with Future Trends Analysis …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rapid Prototyping Materials Market Size, Share & Trends Analysis Report By Type (Polymer, Metals & Alloys, Ceramics), Form (Filament, Ink, And Powder), Function (Conceptual Model, Functional Prototype) And End-Use (Aerospace & Defense, Healthcare, Manufacturing & Construction, Consumer Goods & Electronics, Transportation, And Others)- Market Outlook And Industry Analysis 2034"
The global rapid prototyping materials market is…
Wearable Injectors Market Exclusive Report on Current Trends and Future Insights
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Wearable Injectors Market- (By Type of Device (Patch Pump / Injectors, Infusion Pump / Injectors), By Usability (Disposable, Reusable), By Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncological Disorders, Other Disorders)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Wearable Injectors Market…
Veterinary Rehabilitation Services Market Study Analysis with Forecast to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Veterinary Rehabilitation Services Market Size, Share & Trends Analysis Report By Animal Type (Companion, Production, And Wildlife Animals), Therapy Type (Therapeutic Exercises, Manual Therapy, Hydrotherapy, Hot & Cold Therapies, Electrotherapies, Acupuncture, Shockwave Therapy And Other Therapies), Indication (Post-Surgery, Traumatic Injuries, Acute & Chronic Diseases, Developmental Abnormality), And End-Use (Veterinary Rehab Centers & Hospitals, Rescue &…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
